Edesa Biotech (EDSA) traded up 0.36 % during a 24 hours period ending at 03:25 PM Central Europe on Monday 26th. One Edesa Biotech stock can currently be bought for about USD 2.7 on popular exchanges. Current supply of Edesa Biotech stocks is 13.5 mn. Edesa Biotech has a current market capitalization of USD 37.4 mn and approximately USD 51.2 k worth of Edesa Biotech was traded on exchanges in the last 24 hours. Since last month end, Edesa Biotech has traded -31.27 % down. Simple moving average of last 200 days is at USD 5.63. The highest price of past 52 weeks was recorded at USD 20.32 on 05/01/2026. 52 weeks low was at USD 0.72 on 02/20/2026.

Here is how related stocks have performed in the past 24 hours:

  • Kalaris Therapeutics (KLRS) traded down -6.03 % and now trades at USD 1.87. Kalaris Therapeutics has a market capitalisation of USD 44.5 mn.

  • Vulcan Infrastructure And Po (VIP) traded down -0.79 % and now trades at USD 1.26. Vulcan Infrastructure And Po has a market capitalisation of USD 44.5 mn. Vulcan Infrastructure And Po has a current price to earnings ratio of 50.79. VULCAN INFRASTRUCTURE AND PO has issued a brief statement concerning recent market activity. The company noted that its share performance has remained relatively stable, with minor fluctuations observed during the latest trading sessions. Management emphasized continued focus on infrastructure development projects and highlighted ongoing efforts to strengthen operational efficiency. No immediate changes to strategic plans or financial outlook were disclosed, and the company reiterated its commitment to delivering consistent value to investors.

  • Forum Markets (FRMM) traded up 1.5 % and now trades at USD 3.78. Current market capitalisation for Forum Markets is USD 44.6 mn.

  • Solitario (XPL) traded up 6.38 % and now trades at USD 0.5. Current market capitalisation for Solitario is USD 44.5 mn.

  • Sanuwave Health (SNWV) traded down -1.51 % and now trades at USD 5.17. Current market capitalisation for Sanuwave Health is USD 44.9 mn.

About Edesa Biotech

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company operating in the health care sector, specializing in biotechnology. The company offers drugs for the treatment of dermatological and gastrointestinal diseases, acting as an alternative to topical steroids. Edesa Biotech serves patients in the United States and Canada, and its operations are headquartered at Port Hueneme. The company’s website is accessible under www.edesabiotech.com , and it is listed on the Nasdaq stock exchange.